172 related articles for article (PubMed ID: 17709361)
1. Uptake characteristics of fluorodeoxyglucose (FDG) in deep fibromatosis and abdominal desmoids: potential clinical role of FDG-PET in the management.
Basu S; Nair N; Banavali S
Br J Radiol; 2007 Sep; 80(957):750-6. PubMed ID: 17709361
[TBL] [Abstract][Full Text] [Related]
2. Can combined 18F-FDG-PET and dynamic contrast-enhanced MRI predict behavior of desmoid tumors in patients with familial adenomatous polyposis?
Bhandari S; Taylor NJ; Sinha A; Sonoda L; Sanghera B; Wong WL; Goh V; Clark SK
Dis Colon Rectum; 2012 Oct; 55(10):1032-7. PubMed ID: 22965401
[TBL] [Abstract][Full Text] [Related]
3. CT of intraabdominal desmoid tumors: is the tumor different in patients with Gardner's disease?
Kawashima A; Goldman SM; Fishman EK; Kuhlman JE; Onitsuka H; Fukuya T; Masuda K
AJR Am J Roentgenol; 1994 Feb; 162(2):339-42. PubMed ID: 8310922
[TBL] [Abstract][Full Text] [Related]
4. Focal uptake of fluorodeoxyglucose by the thyroid in patients undergoing initial disease staging with combined PET/CT for non-small cell lung cancer.
Yi JG; Marom EM; Munden RF; Truong MT; Macapinlac HA; Gladish GW; Sabloff BS; Podoloff DA
Radiology; 2005 Jul; 236(1):271-5. PubMed ID: 15987980
[TBL] [Abstract][Full Text] [Related]
5. PET imaging characteristics of neuromuscular choristoma and associated desmoid-type fibromatosis.
Marek T; Spinner RJ; Carter JM; Murthy NK; Amrami KK; Broski SM
Acta Neurochir (Wien); 2023 May; 165(5):1171-1177. PubMed ID: 36917362
[TBL] [Abstract][Full Text] [Related]
6. Hodgkin disease: diagnostic value of FDG PET/CT after first-line therapy--is biopsy of FDG-avid lesions still needed?
Schaefer NG; Taverna C; Strobel K; Wastl C; Kurrer M; Hany TF
Radiology; 2007 Jul; 244(1):257-62. PubMed ID: 17581905
[TBL] [Abstract][Full Text] [Related]
7. FDG-PET for prediction of tumour aggressiveness and response to intra-arterial chemotherapy and radiotherapy in head and neck cancer.
Kitagawa Y; Sano K; Nishizawa S; Nakamura M; Ogasawara T; Sadato N; Yonekura Y
Eur J Nucl Med Mol Imaging; 2003 Jan; 30(1):63-71. PubMed ID: 12483411
[TBL] [Abstract][Full Text] [Related]
8. PET imaging of musculoskeletal tumours with fluorine-18 alpha-methyltyrosine: comparison with fluorine-18 fluorodeoxyglucose PET.
Watanabe H; Inoue T; Shinozaki T; Yanagawa T; Ahmed AR; Tomiyoshi K; Oriuchi N; Tokunaga M; Aoki J; Endo K; Takagishi K
Eur J Nucl Med; 2000 Oct; 27(10):1509-17. PubMed ID: 11083540
[TBL] [Abstract][Full Text] [Related]
9. Dual-tracer PET/CT imaging in evaluation of metastatic hepatocellular carcinoma.
Ho CL; Chen S; Yeung DW; Cheng TK
J Nucl Med; 2007 Jun; 48(6):902-9. PubMed ID: 17504862
[TBL] [Abstract][Full Text] [Related]
10. 18F-fluorodeoxyglucose uptake of bone and soft tissue sarcomas in pediatric patients.
Walter F; Federman N; Apichairuk W; Nelson S; Phelps ME; Allen-Auerbach M; Walter MA; Czernin J
Pediatr Hematol Oncol; 2011 Oct; 28(7):579-87. PubMed ID: 21936620
[TBL] [Abstract][Full Text] [Related]
11. Accuracy of fluorodeoxyglucose-positron emission tomography for diagnosis of single bone metastasis: comparison with bone scintigraphy.
Hur J; Yoon CS; Ryu YH; Yun MJ; Suh JS
J Comput Assist Tomogr; 2007; 31(5):812-9. PubMed ID: 17895798
[TBL] [Abstract][Full Text] [Related]
12. 18F-FDG PET/CT and 99mTc-MDP Bone Scintigraphy Findings of Multifocal Desmoid Fibromatosis.
Filizoglu N; Ozguven S; Ones T; Dede F; Erdil TY
Clin Nucl Med; 2024 Mar; 49(3):e111-e112. PubMed ID: 38306384
[TBL] [Abstract][Full Text] [Related]
13. Abdominal Wall Desmoid Fibromatosis Mimics Sarcoma With Intense FDG Uptake on FDG PET/CT.
Xu F; Liu ML; Pastakia B; Liu F
Clin Nucl Med; 2015 Aug; 40(8):e423-5. PubMed ID: 25674878
[TBL] [Abstract][Full Text] [Related]
14. Potential role of FDG PET in the setting of diabetic neuro-osteoarthropathy: can it differentiate uncomplicated Charcot's neuroarthropathy from osteomyelitis and soft-tissue infection?
Basu S; Chryssikos T; Houseni M; Scot Malay D; Shah J; Zhuang H; Alavi A
Nucl Med Commun; 2007 Jun; 28(6):465-72. PubMed ID: 17460537
[TBL] [Abstract][Full Text] [Related]
15. The role of [18F]fluorodeoxyglucose positron emission tomography imaging in the evaluation of hepatocellular carcinoma.
Wudel LJ; Delbeke D; Morris D; Rice M; Washington MK; Shyr Y; Pinson CW; Chapman WC
Am Surg; 2003 Feb; 69(2):117-24; discussion 124-6. PubMed ID: 12641351
[TBL] [Abstract][Full Text] [Related]
16. [Desmoid tumor of the thoraco-abdominal wall characterized with 18F-fluorodeoxyglucose PET/ CT scan. Correlation with magnetic resonance and bone scintigraphy. Review of the literature].
Ramos-Font C; Santiago Chinchilla A; Rebollo Aguirre AC; Rodríguez Fernández A; Medina Benítez A; Llamas Elvira JM
Rev Esp Med Nucl; 2009; 28(2):70-3. PubMed ID: 19406052
[TBL] [Abstract][Full Text] [Related]
17. PET/CT characterization of fibroosseous defects in children: 18F-FDG uptake can mimic metastatic disease.
Goodin GS; Shulkin BL; Kaufman RA; McCarville MB
AJR Am J Roentgenol; 2006 Oct; 187(4):1124-8. PubMed ID: 16985165
[TBL] [Abstract][Full Text] [Related]
18. Uptake in supraclavicular area fat ("USA-Fat"): description on 18F-FDG PET/CT.
Cohade C; Osman M; Pannu HK; Wahl RL
J Nucl Med; 2003 Feb; 44(2):170-6. PubMed ID: 12571205
[TBL] [Abstract][Full Text] [Related]
19. Standardized uptake value based evaluation of lymphoma by FDG and FLT PET/CT.
Wang R; Zhu H; Chen Y; Li C; Li F; Shen Z; Tian J; Yu L; Xu B
Hematol Oncol; 2014 Sep; 32(3):126-32. PubMed ID: 23996464
[TBL] [Abstract][Full Text] [Related]
20. The feasibility of 11C-methionine-PET in diagnosis of solitary lung nodules/masses when compared with 18F-FDG-PET.
Hsieh HJ; Lin SH; Lin KH; Lee CY; Chang CP; Wang SJ
Ann Nucl Med; 2008 Jul; 22(6):533-8. PubMed ID: 18670862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]